Praxis Precision Medicines, Inc.
PRAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $7 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $66 | $63 | $61 | $56 |
| Gross Profit | -$66 | -$63 | -$61 | -$49 |
| % Margin | – | – | – | -654.2% |
| R&D Expenses | $66 | $63 | $61 | $56 |
| G&A Expenses | $13 | $13 | $14 | $15 |
| SG&A Expenses | $13 | $13 | $14 | $15 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$66 | -$63 | -$61 | -$56 |
| Operating Expenses | $13 | $13 | $14 | $15 |
| Operating Income | -$78 | -$76 | -$75 | -$64 |
| % Margin | – | – | – | -857% |
| Other Income/Exp. Net | $4 | $5 | $5 | $5 |
| Pre-Tax Income | -$74 | -$71 | -$69 | -$59 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$74 | -$71 | -$69 | -$59 |
| % Margin | – | – | – | -786.3% |
| EPS | -3.36 | -3.31 | -3.29 | -2.94 |
| % Growth | -1.5% | -0.6% | -11.9% | – |
| EPS Diluted | -3.36 | -3.31 | -3.29 | -2.94 |
| Weighted Avg Shares Out | 22 | 21 | 21 | 20 |
| Weighted Avg Shares Out Dil | 22 | 21 | 21 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $5 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$74 | -$76 | -$75 | -$64 |
| % Margin | – | – | – | -856.3% |